Cargando…
Preliminary Assessment of Reference Region Quantification and Reduced Scanning Times for [(18)F]SynVesT-1 PET in Parkinson's Disease
Synaptic density in the central nervous system can be measured in vivo using PET with [(18)F]SynVesT-1. While [(18)F]SynVesT-1 has been proven to be a powerful radiopharmaceutical for PET imaging of neurodegenerative disorders such as Parkinson's disease (PD), its currently validated acquisitio...
Autores principales: | Smart, Kelly, Uribe, Carme, Desmond, Kimberly L., Martin, Sarah L., Vasdev, Neil, Strafella, Antonio P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10445483/ https://www.ncbi.nlm.nih.gov/pubmed/37622164 http://dx.doi.org/10.1155/2023/1855985 |
Ejemplares similares
-
Lower synaptic density associated with gaming disorder: an (18)F-SynVesT-1 PET imaging study
por: Hou, Jiale, et al.
Publicado: (2023) -
Organocatalytic
Asymmetric Synthesis of SynVesT-1,
a Synaptic Density Positron Emission Tomography Imaging Agent
por: McErlain, Holly, et al.
Publicado: (2022) -
Validation, kinetic modeling, and test-retest reproducibility of [(18)F]SynVesT-1 for PET imaging of synaptic vesicle glycoprotein 2A in mice
por: Bertoglio, Daniele, et al.
Publicado: (2022) -
(18)F-SynVesT-1 PET/MR Imaging of the Effect of Gut Microbiota on Synaptic Density and Neurite Microstructure: A Preclinical Pilot Study
por: Yi, Sue Y., et al.
Publicado: (2022) -
Cortical abnormalities of synaptic vesicle protein 2A in focal cortical dysplasia type II identified in vivo with (18)F-SynVesT-1 positron emission tomography imaging
por: Tang, Yongxiang, et al.
Publicado: (2022)